Study of the adjuvanticity of lysine lipopeptides; carbamate analogs elicit strong Th1 and Th2 response to ovalbumin in mice

被引:8
|
作者
Ismail, Tabasum [2 ]
Shafi, Syed [3 ]
Gupta, Amit [1 ,2 ]
Khajuria, Anamika [2 ]
Sidiq, Tabasum [2 ]
Reddy, Doma Mahendhar [2 ]
Alam, M. Sarwar [3 ]
Qazi, G. N. [3 ]
Kumar, H. M. Sampath [1 ]
机构
[1] Indian Inst Chem Technol, Organ Chem Div 1, Hyderabad 500007, Andhra Pradesh, India
[2] Indian Inst Integrat Med, Synthet & Biol Chem Div, Jammu 180001, India
[3] Hamdard Univ, Fac Sci, Dept Chem, New Delhi 110062, India
关键词
Adjuvants; Lipopeptides; Lysine; Th1; PEPTIDES;
D O I
10.1016/j.intimp.2011.07.016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bacterial lipoproteins and their synthetic analogs are strong immune modulators of the early host responses. In view of the strong adjuvanticity of bacterial lipopeptide mimics bearing lysine residues, a focused library of lipidated dipeptides and tripeptides has been synthesized with a view to understand the pattern of activity vis a vis the site and extent of lipidation. Compounds 4, 5 and 14 stimulate OVA specific IgG titer, neutralization of antibodies (IgG1 and IgG2a). T lymphocyte sub-sets (CD4/CD8) and its production of soluble mediators for Th1 (IFN-gamma)/Th2 (IL-4) cytokines and costimulatory molecules (CD80/CD86) which are ideal traits of immune adjuvants. The results support lipidated lysine dipeptides as potent enhancers of humoral and cell mediated immune responses and thus might become promising immune-adjuvants for self adjuvanted vaccines. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1855 / 1863
页数:9
相关论文
共 50 条
  • [1] Development of novel lipidated analogs of picroside as vaccine adjuvants: Acylated analogs of picroside-II elicit strong Th1 and Th2 response to ovalbumin in mice
    Kumar, H. M. Sampath
    Singh, Parvinder Pal
    Qazi, Naveed A.
    Srinivas, Jada
    Malik, Fayaz
    Sidiq, Tabasum
    Gupta, Amit
    Khajuria, Anamika
    Suri, K. A.
    Satti, N. K.
    Qazi, G. N.
    VACCINE, 2010, 28 (52) : 8327 - 8337
  • [2] Synthesis of novel lipidated iridoid glycosides as vaccine adjuvants: 6-O-Palmitoyl Agnuside elicit strong Th1 and Th2 response to ovalbumin in mice
    Singh, Parvinder Pal
    Bhunia, Debabrata
    Verma, Yogesh Kumar
    Sidiq, Tabasum
    Khajuria, Anamika
    Guptha, Amit
    Pallavi, M. Preethi
    Vamshi, S. Surya
    Qazi, Gulam N.
    Kumar, Halmuthur M. Sampath
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 17 (03) : 593 - 600
  • [3] Ginsenoside Rd elicits Th1 and Th2 immune responses to ovalbumin in mice
    Yang, Zhigang
    Chen, Aqin
    Sun, Hongxiang
    Ye, Yiping
    Fang, Weihuan
    VACCINE, 2007, 25 (01) : 161 - 169
  • [4] Inactivation of Th1 and Th2 cells by feeding ovalbumin
    Mowat, AM
    Steel, M
    Worthey, EA
    Kewin, PJ
    Garside, P
    ORAL TOLERANCE: MECHANISMS AND APPLICATIONS, 1996, 778 : 122 - 132
  • [5] TH1/TH2 immune response
    Dechene, L
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) : 539 - 540
  • [6] Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice
    Shieh, Ying-Hua
    Huang, Huei-Mei
    Wang, Ching-Chiung
    Lee, Chen-Chen
    Fan, Chia-Kwung
    Lee, Yueh-Lun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 24 (02) : 383 - 391
  • [7] Bet V 1 COP-virosomes elicit strong Th1 response in mice
    Kettner, A.
    Amacker, M.
    Fleury, S.
    Stegmann, A.
    Beltrami, V
    Kempers, R.
    Charlon, V
    ALLERGY, 2019, 74 : 320 - 320
  • [8] The Th1/Th2 paradigm and the allograft response
    Strom, TB
    RoyChaudhury, P
    Manfro, R
    Zheng, XX
    Nickerson, PW
    Wood, K
    Bushell, A
    CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) : 688 - 693
  • [9] TH1 VERSUS TH2 IMMUNE RESPONSE
    Emanuel, Shaunagh
    Hawarden, Di
    CURRENT ALLERGY & CLINICAL IMMUNOLOGY, 2018, 31 (02) : 96 - 97
  • [10] TH1/TH2 immune response -: Reply
    von Mutius, E
    Weiland, S
    Renz, H
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 110 (03) : 540 - 540